Johnson & Johnson (JNJ)
| Previous close | 176.10 |
| Open | 179.92 |
| Bid | 175.36 x 900 |
| Ask | 176.00 x 800 |
| Day's range | 176.46 - 177.37 |
| 52-week range | 155.72 - 186.69 |
| Volume | |
| Avg. volume | 7,078,590 |
| Market cap | 462.397B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 24.63 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 4.52 (2.57%) |
| Ex-dividend date | 21 Nov 2022 |
| 1y target est | N/A |
- Zacks
Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $176.10, moving -1.5% from the previous trading session.
- Motley Fool
If You Bought 100 Shares of Johnson & Johnson 10 Years Ago, This Is How Much You Would Have Today
The stability of Johnson & Johnson (NYSE: JNJ) has attracted investors for a long time. The healthcare company with more than 140,000 employees is a Dividend King that has raised its quarterly dividend annually for 60 consecutive years, including a 6.6% bump this year to $1.13 per share, resulting in a yield of about 2.58%. The company has built-in diversity because it is so large and operates in three segments: pharmaceuticals, medtech, and consumer healthcare.
- Motley Fool
3 Top Tech Stocks to Buy During a Recession
Over the past year, rising interest rates and fears of a global recession drove many investors away from higher-growth tech stocks. Here, I'll highlight three of those recession-resistant plays -- Veeva Systems (NYSE: VEEV), Fortinet (NASDAQ: FTNT), and Airbnb (NASDAQ: ABNB) -- and explain why they're still great buys as the bear market drags on. Veeva Systems is the top provider of cloud-based customer relationship management (CRM) services for life science companies.
